Advanced phase I/II studies of targeted gene delivery in vivo: intravenous Rexin-G for gemcitabine-resistant metastatic pancreatic cancer
about
Interventional Nanotheranostics of Pancreatic Ductal AdenocarcinomaA short perspective on gene therapy: Clinical experience on gene therapy of gliomablastoma multiformeNanovectors for anti-cancer drug delivery in the treatment of advanced pancreatic adenocarcinomaClinical Outcomes of Specific Immunotherapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis.Rexin-G®, a tumor-targeted retrovector for malignant peripheral nerve sheath tumor: A case report.Rexin-G, a targeted genetic medicine for cancer.Gammaretroviral vectors: biology, technology and applicationCancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.Library screening and receptor-directed targeting of gammaretroviral vectors.Genetic and molecular alterations in pancreatic cancer: implications for personalized medicine.Overcoming drug resistance in pancreatic cancer.Current advances in retroviral gene therapy.Gene and cell therapy for pancreatic cancer.Nanovector-based therapies in advanced pancreatic cancer.Novel therapies for pancreatic cancer: setbacks and progressNanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research.Engineering protein self-assembling in protein-based nanomedicines for drug delivery and gene therapy.Pancreatic cancer gene therapy: from molecular targets to delivery systems.Immunotherapeutic and oncolytic viral therapeutic strategies in pancreatic cancer.Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date.Antitumoral activity of parvovirus-mediated IL-2 and MCP-3/CCL7 delivery into human pancreatic cancer: implication of leucocyte recruitment.Gene Therapy for Pancreatic Cancer: Specificity, Issues and Hopes.Efficacy and Safety of Pancreas-Targeted Hydrodynamic Gene Delivery in Rats.Emerging Therapeutic Potential of Nanoparticles in Pancreatic Cancer: A Systematic Review of Clinical Trials.Nanomedicine in Action: An Overview of Cancer Nanomedicine on the Market and in Clinical TrialsCurrent status and dilemma of second-line treatment in advanced pancreatic cancer: is there a silver lining?
P2860
Q26744830-A7224763-937A-4D36-9682-76104D572C14Q26849375-2703508C-2C10-48AC-891A-97B6F2BEBF6AQ28077206-966C891C-9C3E-43EF-8AA8-26AB8E5E5517Q30235405-F15D71CD-671B-447B-B6B5-69078193207DQ33748342-78906D9D-3EF7-4023-9361-020C695D362AQ34109646-8B9B5642-BCE0-4C8C-B1A8-9EF7BAB0F9C9Q34223822-901640D3-F67F-45E3-8F93-6B130AF27646Q34447986-3D1C94DE-DB6C-4216-90E4-937D10FD0B73Q34517833-9B1573E3-EC34-4DD4-9B70-E52F3C447AF2Q34657038-98A77B74-E384-4881-8245-81EC51BCFF18Q35036615-B0F94AFF-4137-4D88-BFA1-5EACF0A25874Q35237554-ED4F35F2-9085-4AED-9715-6732A68156E8Q35541787-FFCFA504-2246-4289-B805-245D471BDD7CQ36097175-1C1EBA63-9AFE-4830-BDDB-A4E7423E7ED2Q37107622-2E591116-AA52-4F61-A55D-E782C1F02A35Q37981001-E025A415-CDF5-4B0A-B10D-2E80DE99AD7DQ38150365-1AD01078-2055-4416-80DB-672BB40C4B88Q38161331-E5357186-023A-4083-B38A-0394F9503464Q38221692-8A11F83C-CB5F-4A32-87BE-0B755D60F5EFQ38853466-741CCD37-F2B9-4C06-B626-E1FEFE9EE43FQ39350562-7F21514C-95A3-4126-877A-EFB2359331FEQ39359422-491E891E-ADF6-4EEB-9C60-F27B29AE504EQ46836744-435E8DF5-CDF0-444F-A89E-DCB311606702Q55071436-47E0AE78-64C8-453B-AF90-01796E844B6AQ57618049-D4D57869-08B9-4BC5-A098-0D04391E49D6Q58799265-EA5DE321-BEC3-4DE9-A12A-52DE2B0F7B1E
P2860
Advanced phase I/II studies of targeted gene delivery in vivo: intravenous Rexin-G for gemcitabine-resistant metastatic pancreatic cancer
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Advanced phase I/II studies of ...... t metastatic pancreatic cancer
@ast
Advanced phase I/II studies of ...... t metastatic pancreatic cancer
@en
type
label
Advanced phase I/II studies of ...... t metastatic pancreatic cancer
@ast
Advanced phase I/II studies of ...... t metastatic pancreatic cancer
@en
prefLabel
Advanced phase I/II studies of ...... t metastatic pancreatic cancer
@ast
Advanced phase I/II studies of ...... t metastatic pancreatic cancer
@en
P2093
P2860
P356
P1433
P1476
Advanced phase I/II studies of ...... t metastatic pancreatic cancer
@en
P2093
Dorris Quon
Erlinda M Gordon
Frederick L Hall
Lita Fernandez
Sant P Chawla
Victoria S Chua
William C Blackwelder
P2860
P304
P356
10.1038/MT.2009.228
P577
2009-10-13T00:00:00Z